Acquisition Opportunity ZimVie is undergoing a major corporate acquisition by ARCHIMED as of October 2025, signaling potential realignment of procurement, supplier consolidation, and updated strategic priorities that could open doors for new or renegotiated contracts and extended product partnerships.

Integrated Digital The company employs a digital workflow portfolio and technology stack (iCIMS, Power BI, Adobe Experience Cloud, JD Edwards, Microsoft AD, Zoom) which suggests openness to integrated software, data analytics, and digital patient pathway enhancements that can be paired with implant and biomaterial solutions.

Financial Signals Recent quarterly results show a net sales base in the mid-range with modest net losses but a positive adjusted EBITDA, indicating a potential window for value-focused procurement discussions, bundled offerings, and efficiency-driven solutions.

Global Footprint With headquarters in Florida and multiple global facilities, ZimVie presents opportunities for regional supply chain optimization, localized service models, and regional training or support agreements to accelerate deployment of implants and digital solutions.

Clinical Leadership As a global life sciences leader in dental implants and biomaterials, ZimVie is positioned to benefit from partnerships around clinical science advancement, training, and capital equipment upgrades that enhance implant surgery workflow and outcomes.